Hey EichKing,
Sadly I never left. Have unfortunately read every post. After the clowns were voted in with ease, I said I’d limit my postings. But a couple of people on this board, constantly have absolutely zero concern with anything, but are so proud of their “big buys” at much higher prices. Somehow think it’s brilliant. Yet they’re the first to criticize long timers for investing too early. Seems they’d be down way more than I would ever be. And they did it in a year and a half. That’s the definition of brilliant. As long as Tobias is in, I’m Happy. Seems to have a thing for the black red and gold eh. Wie geht’s.
And now we have a chart lover on board. Too bad they didn’t come across Pluristem one year earlier. Would have thrown the farm at this stock in the pump of 2017. Charts would have been a screaming buy, only to get a 2x4 to the knees when the reason came out. Jokes.
They’re all excited now about Thermo too. Got their hands on this technology 11 years ago...when it was in its infancy. Said this last year that they blew this huge opportunity to be the leaders in manufacturing of cells. Now do a search of bioreactors, 3D bioreactors, single use, 1000L, 2000L. They’re everywhere. Little late to the party. Would have been great to see a guy from Thermo be interviewed about the relationship. Kaki’s words mean jack.
But like always from the goons, be as vague as possible, and keep the shareholders guessing. Just like their inability to do a cc or the absolute joke of something they call a shareholder update. Absolutely laughable, with zero information whatsoever in it. Remember though...they made most milestones.
Where’s the trial enrolment update? Have we ever got one ever. Oh ya, after the IC trial seemed like it had been forgotten about for a couple of years. Have a look at Brainstorm. Every chance they get, they release how their enrolment is moving along. We get crickets. Coincidental, or is enrolment chugging along at a pace similar to IC...pathetic. Fingers crossed for 2018 still Allo.
But hey, the had a PR last year that they want get 40 sites up and running by the end of 2017. In the final quarter of 2018, and still sitting at 39 sites. One more to go and you can celebrate another big milestone made.
Or how about waiting for interim results from HCT. Wow what a delay on that one huh. 2h17 was the date for that one. Along with NYBC. Crickets.
And yes the forgotten ODD’s we got. Preeclampsia steering committee was formed for what? Those guys probably joined for free huh. But the twins are competent and deserved those huge bonuses.
And ARS. Contract talks broke down? Still expecting a contract in 2h17? Now it’s because the order is too big for us to handle. Or we need a thawing device before it’s a go. Didn’t Zami invent one? But but but we’ve been paying quite a few bucks I’d imagine, for our state of the art facility. Didn’t they even expand it a few years ago. Great call guys. Smart businessmen is what we have here. We should just manufacture as many doses as we can regardless of the cost. Who cares if it’s not approved yet. Just do it guys. Feel big...strong...just like bull. Top secret for sure. Almost 18 months since pivotal trial ended. No need for concern though. Heard the NHP union voted to strike last year.
Funny though that they are trying to do some sort of manufacturing deal. Or how about the drastic reduction in shoes this year. You’re not reading these posts here are you Kaki and Quackie.
It’s funny that I stopped posting for quite a period of time, but the same unanswered questions remain, as if I’m stuck in a time warp. Miss after miss, unwarranted bonus after bonus. Some things never change. Except the downtrend in our price. Don’t need any chart to show me that. It’s the one thing the twins do best.
But have zero concerns whatsoever. It’s all good. Tobias says so and he gets paid consulting fees.
You know what? Our original twin gets paid via consulting fees. Too bad when that job was posted it came with a no experience necessary clause. Now we have a mini me accountant too. And people wonder why our price is where it is. Controller. Too funny.
